Concepedia

Cuicui Lyu

CL

1

Publications

12

Citations

1

H-Index

2022

Active since

Affiliations

Shanghai CASB Biotechnology (China)(Current)

Cuicui Lyu is an author at Shanghai CASB Biotechnology (China) specializing in t cell immunity, autoimmunity, and tumor immunity.

Top concepts

MedicineOncologyPathologyImmunologyAutoimmunityImmunotherapyTumor ImmunityT Cell ImmunityRadiation OncologyCombination Therapy

Publications per year

2022–2022

1

Publications

1

Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti‐CD19‐chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B‐cell lymphoma and high tumor burden

Juan Mu, Haobin Deng, Cuicui Lyu et al. · Hematological Oncology · 2022 · 12 citations

Inhibitor Maintenance Therapy, Immunology, Pathology +16

Rows per page

1–1 of 1